Company
alebund
一家专注于开发治疗肾脏疾病及相关慢性病创新药物的综合性生物制药公司
Also known as Alebund Pharmaceuticals
- Status
- IPOas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- China
- Legal name
- Alebund Pharmaceuticals
Claim, correct or request removal
Record updated 28 September 2026
About
Relying on its deep R&D foundation in the field of kidney disease, high-standard production base and commercialization layout, Libang Pharmaceutical has built end-to-end capabilities from product R&D to commercial rollout, and is committed to giving patients worldwide earlier access to innovative treatment options.
About the company
- Status notes
- 礼邦医药（09637.HK）正式在香港联合交易所主板挂牌上市
Products
- Other
- AP301
- Other
- AP306
- Other
- AP308
Loading relationship preview